<DOC>
	<DOCNO>NCT01592266</DOCNO>
	<brief_summary>PET/CT reliable tool evaluation treatment response number cancer . F18-FLT precursor DNA high uptake bone marrow part normal biodistribution . Highly increase uptake radiopharmaceutical show number hematologic disease either bone marrow extramedullary . F18-FLT PET/CT provide tool whole body assessment activity bone marrow well early estimation treatment efficacy lack . In addition , noninvasive study replace bone marrow biopsy predict response vs. non response therapy .</brief_summary>
	<brief_title>F18-FLT PET/CT Tool Assessment Myeloablative Treatment Patients With Acute Myeloid Leucemia ( AML )</brief_title>
	<detailed_description />
	<criteria>new diagnosis AML pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>FLT</keyword>
	<keyword>PET</keyword>
	<keyword>bone marrow</keyword>
	<keyword>AML</keyword>
</DOC>